Answers are grounded in this paper and cite their sources.
Evaluates the impact of chicken liver hydrolysate on growth and palatability in eels, indicating its potential for aquaculture.
This study evaluated the effects of Harim-CLH, a chicken liver hydrolysate manufactured from Harim, Korea, on the palatability, growth performance, and physiological responses of Anguilla japonica eels. Eels were fed either a control diet (CTL) or an experimental diet (CLH-1), in which 1% of fishmeal in the CTL was replaced with Harim-CLH, for eight weeks. We assessed growth performance by measuring weight gain rate (WGR) and total feed intake (TFI); feed efficiency (FE) was also recorded. Biological indices (condition Index and hepatosomatic Index), non-specific immune responses (lysozyme and phagocytic activities), and plasma biochemical factors (glutamate oxaloacetate transaminase, high-density lipoprotein cholesterol, total protein, alkaline phosphatase, triglycerides, glucose, and total cholesterol) were analyzed. The CLH-1 group exhibited a significant increase in WGR and TFI, while FE did not show significant differences. There were no significant changes in the liver weight index, non-specific immune responses, or blood biochemical factors. Attractancy to the CLH-1 diet was lower than CTL, but not significantly, whereas palatability was significantly higher. Next-generation sequencing analysis of brain, intestine, and liver tissues revealed no gene expression differences in the brain but identified variations in non-coding RNA and genes with unknown functions in the intestine and liver. This study highlights the potential of Harim-CLH to enhance growth and feed palatability in aquaculture diets without adverse effects on health indices.
No takes yet. Share an insight, caveat, or question.
Ahn et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: